HUP0203282A2 - Transdermal drug delivery devices comprising (r)-(z)-i-azabicyclo(2.2.1)heptan-3-one,0-(3(3-methoxyphenyl)-2-propynyl)oxime - Google Patents
Transdermal drug delivery devices comprising (r)-(z)-i-azabicyclo(2.2.1)heptan-3-one,0-(3(3-methoxyphenyl)-2-propynyl)oximeInfo
- Publication number
- HUP0203282A2 HUP0203282A2 HU0203282A HUP0203282A HUP0203282A2 HU P0203282 A2 HUP0203282 A2 HU P0203282A2 HU 0203282 A HU0203282 A HU 0203282A HU P0203282 A HUP0203282 A HU P0203282A HU P0203282 A2 HUP0203282 A2 HU P0203282A2
- Authority
- HU
- Hungary
- Prior art keywords
- heptan
- propynyl
- oxime
- methoxyphenyl
- azabicyclo
- Prior art date
Links
- NGAZZOYFWWSOGK-UHFFFAOYSA-N heptan-3-one Chemical compound CCCCC(=O)CC NGAZZOYFWWSOGK-UHFFFAOYSA-N 0.000 title 2
- 150000002923 oximes Chemical class 0.000 title 1
- 238000013271 transdermal drug delivery Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 5
- 239000004820 Pressure-sensitive adhesive Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány az (R)-(Z)-1-aza-biciklo[2.2.1)heptan-3-on, O-[3-(3-metoxi-fenil)-2-propinil)-oxim gyógyszer transzdermális adagolásáraalkalmas eszközökre vonatkozik. A találmány szerinti, (R)-(Z)-1-aza-biciklo[2.2.1]heptan-3-on, O-[3-(3-metoxi-fenil)-2-propinil)-oximtranszdermális adagolására alkalmas eszközök a) gyógyászatiszempontból hatásos mennyiségű gyógyszert és egy első nyomásérzékenytapadóképes anyagot magában foglaló gyógyszertároló rétegből és b) agyógyszertároló réteg egyik lapjához tapadó, gyógyszerként egy másodiknyomásérzékeny tapadóképes anyagot magában foglaló, bőrrel érintkezőrétegből állnak. ÓThe invention is for devices suitable for transdermal administration of the drug (R)-(Z)-1-aza-bicyclo[2.2.1)heptan-3-one, O-[3-(3-methoxyphenyl)-2-propynyl)-oxime applies. Devices suitable for transdermal administration of (R)-(Z)-1-aza-bicyclo[2.2.1]heptan-3-one, O-[3-(3-methoxy-phenyl)-2-propynyl)-oxime according to the invention a) they consist of a drug storage layer containing a therapeutically effective amount of medicine and a first pressure-sensitive adhesive material and b) a skin-contacting layer adhering to one side of the medicine storage layer and containing a second pressure-sensitive adhesive material as medicine. HE
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16236899P | 1999-10-28 | 1999-10-28 | |
| US69753200A | 2000-10-26 | 2000-10-26 | |
| PCT/US2000/029702 WO2001030316A2 (en) | 1999-10-28 | 2000-10-27 | Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0203282A2 true HUP0203282A2 (en) | 2003-02-28 |
| HUP0203282A3 HUP0203282A3 (en) | 2003-11-28 |
Family
ID=26858694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0203282A HUP0203282A3 (en) | 1999-10-28 | 2000-10-27 | Transdermal drug delivery devices comprising (r)-(z)-i-azabicyclo(2.2.1)heptan-3-one,0-(3(3-methoxyphenyl)-2-propynyl)oxime |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1229905A2 (en) |
| JP (1) | JP2003512414A (en) |
| KR (1) | KR20020047298A (en) |
| CN (1) | CN1384738A (en) |
| CA (1) | CA2388611A1 (en) |
| CZ (1) | CZ20021496A3 (en) |
| HU (1) | HUP0203282A3 (en) |
| IL (1) | IL149115A0 (en) |
| MX (1) | MXPA02004151A (en) |
| NO (1) | NO20022013L (en) |
| NZ (1) | NZ518436A (en) |
| PL (1) | PL354651A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10333393A1 (en) * | 2003-07-23 | 2005-02-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with the active ingredient pramipexole |
| JP4567998B2 (en) * | 2004-03-22 | 2010-10-27 | コスメディ製薬株式会社 | Hydrophilic external skin pressure-sensitive adhesive composition and hydrophilic patch using hydrophilic pressure-sensitive adhesive |
| US9017301B2 (en) * | 2007-09-04 | 2015-04-28 | Mylan Technologies, Inc. | Transdermal drug delivery systems comprising a coated release liner |
-
2000
- 2000-10-27 HU HU0203282A patent/HUP0203282A3/en unknown
- 2000-10-27 KR KR1020027005442A patent/KR20020047298A/en not_active Application Discontinuation
- 2000-10-27 MX MXPA02004151A patent/MXPA02004151A/en unknown
- 2000-10-27 JP JP2001532736A patent/JP2003512414A/en active Pending
- 2000-10-27 EP EP00980246A patent/EP1229905A2/en not_active Withdrawn
- 2000-10-27 IL IL14911500A patent/IL149115A0/en unknown
- 2000-10-27 NZ NZ518436A patent/NZ518436A/en unknown
- 2000-10-27 CZ CZ20021496A patent/CZ20021496A3/en unknown
- 2000-10-27 PL PL00354651A patent/PL354651A1/en not_active Application Discontinuation
- 2000-10-27 CA CA002388611A patent/CA2388611A1/en not_active Abandoned
- 2000-10-27 CN CN00815015A patent/CN1384738A/en active Pending
-
2002
- 2002-04-26 NO NO20022013A patent/NO20022013L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1384738A (en) | 2002-12-11 |
| HUP0203282A3 (en) | 2003-11-28 |
| PL354651A1 (en) | 2004-02-09 |
| CA2388611A1 (en) | 2001-05-03 |
| CZ20021496A3 (en) | 2003-04-16 |
| NZ518436A (en) | 2002-11-26 |
| MXPA02004151A (en) | 2002-10-17 |
| IL149115A0 (en) | 2002-11-10 |
| EP1229905A2 (en) | 2002-08-14 |
| JP2003512414A (en) | 2003-04-02 |
| KR20020047298A (en) | 2002-06-21 |
| NO20022013L (en) | 2002-06-28 |
| NO20022013D0 (en) | 2002-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100312764B1 (en) | Intravaginal delivery system | |
| US5099832A (en) | Packaged sterile adhesive dressing | |
| EP2049055B1 (en) | Conformable wound dressing | |
| HUP0101512A2 (en) | Adhesive microsphere drug delivery composition, process for its preparation and device containing it | |
| HUP0001748A2 (en) | Transdermal device for the delivery of testosterone | |
| US20140249492A1 (en) | Transdermal patch incorporating active agent migration barrier layer | |
| CA2329128A1 (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
| HUP9901991A2 (en) | Transdermal device for the delivery of flurbiprofen | |
| CA2302601A1 (en) | Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience | |
| EP0887075A3 (en) | Adhesive mixture for transdermal delivery of highly plasticizing drugs | |
| DE69830095D1 (en) | Pharmaceutical, cosmetic or dermo-pharmaceutical patch for the administration of several different active substances | |
| WO2001026705A3 (en) | A dual adhesive transdermal drug delivery system | |
| AU1302499A (en) | Buffered drug formulations for transdermal electrotransport delivery | |
| CA2268187A1 (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
| AU622775B2 (en) | A plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release, process for the production of the plaster and the use thereof | |
| AU6675198A (en) | Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use | |
| HU204203B (en) | Plaster containing active ingredient which feeding the active ingredient into skin in controlled manner | |
| EE04997B1 (en) | Pharmaceutical composition containing loteprednol and antihistamines, a medicament containing these agents, a process for the preparation of the medicament and use of a combination of these agents | |
| CA2004597A1 (en) | Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo-[4,5-c]quinoline-4-amine | |
| HUP0102498A2 (en) | Transdermal therapeutic system containing steroid hormones and crystallization inhibitors | |
| NZ335924A (en) | Flat transdermal medicated self-adhesive patch having a temporary peel off foil that extends over the patch and has two recesses with a break line extending from the recesses | |
| HUP0203282A2 (en) | Transdermal drug delivery devices comprising (r)-(z)-i-azabicyclo(2.2.1)heptan-3-one,0-(3(3-methoxyphenyl)-2-propynyl)oxime | |
| EP1013734A4 (en) | Gel-form pressure-sensitive adhesive, and adhesive material and adhesive medicinal preparation both containing the same | |
| CA2336712A1 (en) | Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels | |
| AU7291996A (en) | Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction |